WebBanao.Com

German biotech Kupando raises €10M more to take its innate immunity drug into the clinic

An extension to the company’s Series A brings total funding to €23 million and clears the path for the first human trial of KUP101, a dual TLR agonist targeting solid tumours and drug-resistant infections. Most immunotherapy research in oncology has concentrated on the adaptive immune system, the learned, antibody-generating machinery that checkpoint inhibitors like pembrolizumab […]

This story continues at The Next Web

German biotech Kupando raises €10M more to take its innate immunity drug into the clinic Read More »

DLSS 5: Has Nvidia’s AI graphics technology gone too far?

Nvidia has revealed a new “3D guided neural rendering model” called DLSS 5 that can change a game’s lighting and materials in real-time, and… many gamers aren’t happy. From DLSS 5 memes to complaints about how it’s “yassified” Resident Evil Requiem characters in demos, the first impression has not been a good one, no matter […]

DLSS 5: Has Nvidia’s AI graphics technology gone too far? Read More »

Shopping Cart